A D Aravinthan

[A D Aravinthan @ADAravinthan]

Hepatocyte senescence fuels HCC development—can mTOR inhibition turn the tide? Exploring its chemo-prophylactic potential. #LiverCancer #mTOR #Senescence https://t.co/ASqPAUbBpm… @MamathaBhat3
https://t.co/L9Zn4TfTBb

[A D Aravinthan @ADAravinthan]

@LTxJournal @navpalani @NeilRajJ1 @AsraniSumeet

[Liver Transplantation Journal (LTxJournal) @LTxJournal]

Interested in earning MOC?

Check out this February MOC article:
Long-term outcomes (beyond 5 years) of liver transplant recipients—A transatlantic multicenter study
by Palaniyappan et al

https://t.co/ylV2Oiogxr

#livertwitter #livertransplant

[Alan Karthikesalingam @alan_karthi]

*New Research Paper* - Diagnostic conundrums are an unsolved grand challenge for AI. We present a new research LLM optimized for differential diagnosis (DDx), tested in @NEJM challenges. Our LLM outperformed clinicians & other LLMs... (1/6) https://t.co/KwRbtIhvJe

[BMJ Open Gastro @BMJOpen_Gastro]

Read the paper by Parker et al entitled

"Quality standards for the management of alcohol-related liver disease: consensus recommendations from the @BASLedu and @BritSocGastro ARLD special interest group" via https://t.co/3wqIXOda7U

@DrStevenMasson @DrADhanda @liver_dietitian

[Neil Rajoriya @NeilRajJ1]

Post CCT Fellowships for Hepatology & Liver Transplantation in the busy Birmingham UK Liver Transplant centre now out! Contact me or @abhichauhan for details.

https://t.co/zBtWNn1gov

[Jasmohan Bajaj @JasmohanBajaj]

✅truly 🌎 nature of #cirrhosis #CLEARED Consortium with SC representation from all continents and equitable participation from collaborators to make this paper possible⤵️
https://t.co/l3UwCXKLp9 @LancetGastroHep Collaborators are welcome as enroll more pts! Join us! @paimadhu

[JHEP Reports @JHEP_Reports]

🟪NEW Article in press❕

Identification and characterisation of a rare MTTP variant underlying hereditary #nonalcoholicfattyliverdisease

🔓#OpenAccess at👉https://t.co/guUkSsI3vZ

#NAFLD
#LiverTwitter

[Christopher Clarke @chrisgdclarke]

National survey of HCC surveillance practice demonstrates an inconsistent approach to poor views with US HCC surveillance.
Should we use US LI-RADS routinely?
@DovePress @AnmolGangi @NottsLiverTeam @JamesMFranklin @ADAravinthan
https://t.co/oSJIAz07Rx

[NottsLiver @NottsLiverTeam]

The inconsistent approach of #HCC surveillance in the UK despite clear national guidelines.
https://t.co/bhJCXewoLQ
@chrisgdclarke @JamesMFranklin @ADAravinthan

[Jamie Franklin @JamesMFranklin]

Our Abdominal Radiology jobs @UHD_NHS are live! Come and work with a brilliant, supportive team in a fantastic location.

Where else will you get views like this on the commute to work!

https://t.co/erSOjh09HM

[Early Cancer Institute, University of Cambridge @EarlyCancerCam]

📢Fantastic opportunity to join @Matt_Hoare20 as a research associate, working in close collaboration with Prof Nitzan Rosenfeld @CRUK_CI
Apply by 10th May.

[Fotios Sampaziotis @FSampaziotis]

We are recruiting! Our group is looking for a research associate/lab manager to join us at @SCICambridge! Please retweet and help us find the right candidate for one of the most important roles within the lab. More information and application: https://t.co/v6l6ggQlUk

[Thomas Reiberger @ReibergerThomas]

#BavenoVII concept of #cirrhosis #recompensation:

🧐 natural history of hepatic recompensation
🔀modifying factors
❓non-invasive biomarkers of recompensation
⚙️molecular mechanisms of disease regression

#livertwitter
📕https://t.co/dcqaJIEXFs

[Global Cancer Observatory (GCO) @GLOBOCAN_GCO]

It's #LiverCancerAwarenessMonth!

Just out in @JHepatology: @HarrietJR_ & colleagues assess the🌍burden of #livercancer using #GLOBOCAN2020 estimates.

Liver cancer is a major cause of death in many countries and this burden is predicted to rise by 2040.
🔗https://t.co/o5viVo9CxJ

[Christopher Clarke @chrisgdclarke]

Nottingham making some great steps in reproduction of organs for training and pre surgical planning. 3D printing + 😁

Here’s a photo of me scanning the 3D printed liver. Vessels have fluid in…

https://t.co/uLwgvqNjnk @TrentUni @NUHRadiology @nottmhospitals @ResearchNuh

[A D Aravinthan @ADAravinthan]

#CellSenescence and SASP - novel anti-fibrotic therapeutic target

[NottsLiver @NottsLiverTeam]

Here’s our provocative hypothesis-generating study demonstrating a direct and causal relationship between #hepatocyte #senescence and #LiverFibrosis, driven by SASP factors, potential #antifibrotic therapeutic target.
Read it here: https://t.co/ojYJVYi3If
#LiverTwitter

[NottsLiver @NottsLiverTeam]

First UK clinical prevalence estimation of Wilson's disease study from Nottingham is out in @JHEP_Reports.
Clinical prevalence is significantly lower (1/64,516) than the genetic prevalence (1/7026).
@nottmhospitals @NottmBRC @MedicineUoN @ADAravinthan
https://t.co/kHh1dHW51j